Prime Vaccines Profile
Key Indicators
- Authorised Capital ₹ 9.00 M
- Paid Up Capital ₹ 6.09 M
- Company Age 40 Year, 8 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.90 M
- Revenue Growth -100.00%
- Profit Growth 22.70%
- Ebitda 19.40%
- Net Worth -0.26%
- Total Assets -0.00%
About Prime Vaccines
Prime Vaccines Private Limited (PVPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 February 1985 and has a history of 40 years. Its registered office is in Rangareddy, Telangana, India.
The Corporate was formerly known as Behring Pharma Private Limited. The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.00 M and a paid-up capital of Rs 6.09 M.
The company currently has active open charges totaling ₹1.90 M.
Pratap Thota and Thota Reddy serve as directors at the Company.
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230TG1985PTC005312
- Company No.
005312
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Feb 1985
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Prime Vaccines?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Thota Reddy  | Managing Director | 23-Feb-2012 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pratap Thota | Director | 15-Feb-1985 | Current |
Financial Performance of Prime Vaccines.
Prime Vaccines Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial improvement in profitability, with a 22.7% increase in profit. The company's net worth dipped by a decrease of 0.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prime Vaccines?
Unlock access to Prime Vaccines's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹1.90 M
₹0
Charges Breakdown by Lending Institutions
- Global Trust Bank Ltd. : 0.19 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Mar 2003 | Global Trust Bank Ltd. | ₹1.90 M | Open |
How Many Employees Work at Prime Vaccines?
Unlock and access historical data on people associated with Prime Vaccines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prime Vaccines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prime Vaccines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
